BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Good Start Genetics, Inc. Appoints Mark Adams, Ph.D. to Chief Information Officer


9/11/2013 1:11:33 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass., September 11, 2013 - Good Start Genetics®, Inc., an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability, today announced the appointment of R. Mark Adams, Ph.D. to chief information officer.

“Good Start Genetics is focused on developing commercial applications of our proprietary NGS technology that build on our current market-leading carrier screening test, GoodStart Select™,” said Don Hardison, president and chief executive officer of Good Start Genetics. “Good Start Genetics is an innovator in the healthcare information space, and adding Mark to our team further strengthens our ability to translate human genomics into clinically actionable tests for the reproductive health space and beyond.”

Dr. Adams has worked in the field of bioinformatics and data analytics for more than 15 years and brings extensive experience in the strategy, design, and implementation of large-scale informatics organizations and systems in support of key strategic initiatives. He joins Good Start Genetics from Bridgewater Associates, Ltd., where he developed unique data warehousing and machine learning approaches to support the world’s largest hedge fund. Previously, Dr. Adams was a principal with Booz Allen Hamilton, where he developed a leading biomedical informatics consulting practice with a primary focus on informatics strategy for clients in the commercial, government, and non-profit markets. A pioneer in the use, development and deployment of large-scale, open-source software in the national and international bioinformatics community, Dr. Adams is also an expert on building communities comprised of academic, industry, and government partners to fund and address health care issues. Dr. Adams led some of the earliest commercial bioinformatics efforts to explore and use genomic and genetic variation data at Variagenics (Cambridge, MA,) where he was vice president of bioinformatics, and Incyte (Palo Alto, CA) where he worked with Temple Smith, Ph.D., to build the company’s first informatics pipeline, supporting high-throughout SNP genomics. Dr. Adams holds a B.A. from Oberlin College and a Ph.D. from Baylor College of Medicine.

“It is a privilege to join the team at Good Start Genetics,” said Dr. Adams. “The company’s CAP- and CLIA-certified, high-complexity laboratory is generating unique and voluminous genomic data through its proprietary NGS platform. We are well-positioned to combine that growing data set with public data sources to take advantage of emerging data science approaches and develop unique and highly-valuable intellectual property.”

“Good Start Genetics is on the leading edge of responsible, clinically relevant NGS-based testing, and I look forward to contributing my expertise to expand our proprietary platform and to deliver valuable information to patients and healthcare practitioners,” continued Dr. Adams.

About Good Start Genetics, Inc.

Good Start Genetics is an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability combined with other technologies to deliver best-in-class tests for routine genetic screening. Through its GoodStart Select™ offering, the company provides the most comprehensive and clinically actionable set of tests for known and novel mutations that cause inherited diseases. Good Start’s NGS capabilities can be applied to multiple disease areas, including pre-conception carrier screening in the in-vitro fertilization setting. For more information, please visit www.goodstartgenetics.com.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES